Martin E W Hemels Selected Research

Anti-Arrhythmia Agents

10/2018	Randomized Controlled Trial of Surgical Versus Catheter Ablation for Paroxysmal and Early Persistent Atrial Fibrillation.
11/2006	The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm.
7/2006	Predictors of non-pharmacological intervention in patients with paroxysmal atrial fibrillation: Value of neuroticism.
5/2006	Favorable long-term outcome of Maze surgery in patients with lone atrial fibrillation.
2/2006	Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin E W Hemels Research Topics

Disease

19	Atrial Fibrillation 01/2024 - 05/2006
4	Bradycardia 11/2023 - 02/2006
4	Hemorrhage 08/2023 - 12/2019
3	Stroke (Strokes) 01/2022 - 12/2019
3	Infections 11/2021 - 12/2018
2	Frailty 08/2023 - 12/2019
2	Neoplasms (Cancer) 02/2023 - 01/2019
2	Heart Failure 01/2022 - 01/2020
2	Cardiac Arrhythmias (Arrythmia) 12/2019 - 11/2006
1	Heart Arrest (Cardiac Arrest) 12/2023
1	Cognitive Dysfunction 11/2023
1	Ischemic Stroke 02/2023
1	Inflammation (Inflammations) 07/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 07/2022
1	Atherosclerosis 07/2022
1	Thrombosis (Thrombus) 01/2022
1	Venous Thromboembolism 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Pain (Aches) 02/2020
1	Mitral Valve Stenosis (Mitral Stenosis) 12/2019
1	Tachycardia (Tachyarrhythmias) 10/2018
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2015
1	Systolic Heart Failure 04/2007
1	Heart Diseases (Heart Disease) 05/2006

Drug/Important Bio-Agent (IBA)

10	AnticoagulantsIBA 08/2023 - 01/2015
7	Vitamin K FDA Link 01/2024 - 12/2019
5	Anti-Arrhythmia AgentsIBA 10/2018 - 02/2006
4	N(4)-oleylcytosine arabinosideIBA 08/2023 - 12/2019
2	Verapamil (Calan)FDA LinkGeneric 11/2023 - 09/2006
2	Indicators and Reagents (Reagents)IBA 08/2023 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2022
2	Cefazolin (Ancef)FDA LinkGeneric 11/2021 - 12/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2019 - 12/2018
1	coumarinIBA 01/2024
1	Factor Xa InhibitorsIBA 01/2024
1	Diltiazem (Cardizem)FDA LinkGeneric 11/2023
1	apixabanIBA 01/2022
1	Vancomycin FDA LinkGeneric 11/2021
1	Cephalexin (Cefalexin)FDA LinkGeneric 11/2021
1	Bacitracin (Baci-Rx)FDA LinkGeneric 11/2021
1	edoxabanIBA 06/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 03/2008
1	CalciumIBA 09/2006
1	Digoxin (Digitek)FDA LinkGeneric 09/2006

Therapy/Procedure

7	Therapeutics 12/2023 - 11/2006
2	Ligation 02/2020 - 10/2018
2	Electric Countershock (Cardioversion) 04/2007 - 09/2006
1	Polypharmacy 11/2023
1	Off-Label Use 01/2022
1	Ablation Techniques 01/2022
1	Drug Tapering 01/2022
1	Percutaneous Coronary Intervention 01/2021
1	Catheters 02/2020
1	Aftercare (After-Treatment) 02/2020
1	Device Removal (Removal, Device) 12/2019
1	Catheter Ablation 10/2018
1	Maze Procedure 05/2006